4,233 Shares in Masimo Co. (NASDAQ:MASI) Purchased by Oak Thistle LLC

Oak Thistle LLC acquired a new position in shares of Masimo Co. (NASDAQ:MASIFree Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 4,233 shares of the medical equipment provider’s stock, valued at approximately $496,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Eminence Capital LP purchased a new stake in Masimo during the 3rd quarter worth about $90,859,000. Teachers Retirement System of The State of Kentucky increased its position in Masimo by 93.8% during the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 16,541 shares of the medical equipment provider’s stock worth $1,450,000 after purchasing an additional 8,004 shares in the last quarter. Comerica Bank purchased a new stake in Masimo in the 3rd quarter valued at about $8,454,000. Sei Investments Co. grew its holdings in Masimo by 224.5% in the 3rd quarter. Sei Investments Co. now owns 183,940 shares of the medical equipment provider’s stock valued at $16,128,000 after buying an additional 127,249 shares during the period. Finally, Massachusetts Financial Services Co. MA acquired a new position in shares of Masimo during the 3rd quarter valued at about $132,699,000. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Stock Performance

Masimo stock opened at $140.64 on Thursday. The company has a current ratio of 2.18, a quick ratio of 1.22 and a debt-to-equity ratio of 0.64. The stock has a market cap of $7.44 billion, a P/E ratio of 93.14 and a beta of 0.97. Masimo Co. has a 52 week low of $75.22 and a 52 week high of $198.00. The stock has a 50 day moving average of $133.75 and a 200-day moving average of $110.74.

Masimo (NASDAQ:MASIGet Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The medical equipment provider reported $1.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.43. The business had revenue of $548.90 million for the quarter, compared to analyst estimates of $545.69 million. Masimo had a return on equity of 13.77% and a net margin of 3.98%. The business’s revenue was down 11.0% compared to the same quarter last year. During the same period in the prior year, the company posted $1.32 EPS. On average, analysts expect that Masimo Co. will post 3.51 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on MASI. Jefferies Financial Group reaffirmed a “hold” rating and set a $121.00 price objective (up previously from $107.00) on shares of Masimo in a research note on Tuesday, January 30th. Wells Fargo & Company raised shares of Masimo from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $117.00 to $160.00 in a research note on Monday, March 25th. StockNews.com raised shares of Masimo from a “sell” rating to a “hold” rating in a research note on Friday, March 29th. Stifel Nicolaus upped their price objective on shares of Masimo from $125.00 to $148.00 and gave the company a “hold” rating in a research note on Monday, March 25th. Finally, Needham & Company LLC cut Masimo from a “buy” rating to a “hold” rating in a research note on Wednesday, January 3rd. Six equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $134.29.

Check Out Our Latest Report on MASI

Masimo Company Profile

(Free Report)

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.

Featured Stories

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASIFree Report).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.